The bark of Machilus thunbergii was extracted with 80% aqueous methanol (MeOH), and the concentrated extract was partitioned using ethyl acetate (EtOAc), butanol (n-BuOH), and H 2 O, successively. From the EtOAc fraction, five lignans were isolated through the repeated silica gel, octadecyl silica gel (ODS) and, Sephadex LH-20 column chromatography. Based on nuclear magnetic resonance (NMR), mass spectroscopy (MS), and infrared spectroscopy (IR) spectroscopic data, the chemical structures of the compounds were determined to be machilin A (1), machilin F (2), licarin A (3), nectandrin A (4), and nectandrin B, (5). This study presents comparative account of five lignans from M. thunbergii bark contributing inhibition of low density lipoprotein (LDL), ACAT-1, and ACAT-2. Compounds 2-5 showed varied degree of antioxidant activity on LDL with IC 50 values of 2.1, 11.8, 15.3, and 4.1 µM. Compounds 1, 2, and 3 showed inhibition activity on ACAT-1 with values 63.4±6.9% (IC 50 =66.8 µM), 53.7±0.9% (IC 50 =109.2 µM), and 78.7±0.2% (IC 50 = 40.6 µM), respectively, at a concentration of 50 mg/mL, and on ACAT-2 with values 47.3±1.5% (IC 50 =149.7 µM), 39.2±0.2% (IC 50 =165.2 µM), and 52.1±1.0% (IC 50 =131.0 µM), respectively, at a concentration of 50 mg/mL.
Machilus thunbergii Siebold & Zuccarinii (Lauraceae) is a widely distributed tree used in Korean traditional medicine [Kim, 1984] . The cortex of the plant is used for treatment of leg edema, abdominal distension, and pain [Chung and Shin, 2000] . Several lignans and neolignans have been reported from the bark of this plant [Shimomura et al., 1987; 1988] . Previous studies on the bark of M. thunbergii reported nitric oxide synthesis inhibitory butanolides [Kim and Ryu, 2003] . Some lignans from the bark have been shown to be antioxidant [Yu et al., 2000] , melanin biosysnthesis inhibitory [Li et al., 2003] , caspase-3 activating [Park et al., 2004] , and neuroprotective [Ma et al., 2004; . In this study we isolated 5 lignans and investigated on their inhibition effect on LDL-oxidation and ACAT-1 and ACAT-2 activities.
Oxidation of low-density lipoprotein (LDL) is considered as an early event in the development of atherosclerosis [Glass and Witztum, 2001 ]. Antioxidants such as probucol, N,N'-diphenyl phenylenediamine, and butylated hydroxy-toluene (BHT) have been shown to decrease the degree of oxidation and the extent of atheromatous lesions in animal models of atherosclerosis, but have side effects [Jialal and Devaraj, 1996] . Thus antioxidants from natural source are attractive alternatives. Cholesterol acyltransferase (ACAT) catalyses the acylation of cholesterol to cholesteryl ester and it exists in two isoforms, ACAT-1 and ACAT-2. ACAT-1 is in charge of foam cell formation in macrophages, whereas ACAT-2 controls the cholesterol absorption in intestinal mucosal cells [Rudel et al., 2001] . Therefore, ACAT inhibition is a useful strategy for treating hypercholesterolemia and atherosclerosis by the effect of lowering plasma cholesterol in humans [Lawrence and Gregory, 2000] .
The dried bark of M. thunbergii was received from Green Flower Cosmetics Co., in 2009 and was identified by Prof. DaeKeun Kim, College of Pharmacy, Woosuk University, Jeonju, Korea. A voucher specimen (KHU-090826) was deposited at the laboratory of Natural Products Chemistry, Kyung Hee University, Yongin, Korea. The dried and powdered bark of M. thunbergii (500 g) was extracted two times with 80% aqueous methanol ( H-NMR (400 MHz, CDCl 3 , δ) 6.72 (2H, d, J=8.0 Hz, H-5, 5'), 6.67 (2H, br.s, H-2, 2'), 6.57 (2H, dd, J=8.0, 1.6 Hz, H-6, 6'), 5.90 (4H, s, OCH 2 O×2), 2.70 (2H, dd, J=13.5, 4.8 Hz, H-7b, 7'b), 2.26 (2H, dd, J=13.5, 9.2 Hz, H-7a, 7'a), 1.75 (2H, m, H-8, 8') , 0.86 (6H, d, J=6.8 Hz, H-9, 9'); 13 C-NMR (100 MHz, CDCl 3 , δ) 147.34 (C-4, 4'), 145.35 (C-3, 3'), 135.50 (C-1, 1'), 121.72 (C-6, 6'), 109.23 (C-5, 5'), 107.87 (C-2, 2'), 100.64 (OCH 2 O×2), 39.43 (C-7, 7'), 39.05 (C-8, 8'), 16.18 (C-9, 9').
Compound C-NMR (100 MHz, CDCl 3 , δ) 146.24 (C-3, 3'), 144.77 (C-4, 4'), 133.93 (C-1, 1'), 119.09 (C-6, 6'), 113.97 (C-5', 5'), 108.97 (C-2, 2'), 87.24 (C-7, 7'), 55.80 (OCH 3 ×2), 44.25 (C-8, 8'), 12.99 (C-9, 9').
LDL-oxidation assay was carried out using the method described in the literature , with BHT as a positive control. The activities of ACAT-1 and ACAT-2 were determined with the method developed by Brecher and Chan [1980] with slight modifications , with oleic acid anilide (OAA) as a positive control. The assay data are
expressed as mean±SD of three replicated experiments.
In a search of biologically active materials in M. thunbergii, the barks were extracted with MeOH and partitioned into EtOAc, n-BuOH, and H 2 O layers through solvent fractionation. Successive repeated silica gel, ODS, and Sephadex LH-20 c.c. of the obtained fractions led to isolation of five lignans. Structural identifications of these lignans were determined to be machilin A (1), machilin F (2), licarin A (3), nectandrin A (4), and nectandrin B (5) by interpretation of extensive spectroscopic data and comparison of data with those described in the literature [Shimomura et al., 1987; 1988; (Fig.  1) .
The oxidation of LDL cholesterol is an important step in the formation of atherosclerotic lesions [Steinberg et al., 1989; Diaz et al., 1997] . Evidence to support this hypothesis is based in part on observation that demonstrate associations between oxidized LDL cholesterol and both the presence of atherosclerotic lesions [Regnstrom et al., 1992] and the progression of carotid artery atherosclerosis [Salonen et al., 1992] . In order to determine whether the compounds might be effective in the development of hypercholesterolemic or antiatherogenic agents, their potential for inhibiting LDL oxidation was evaluated. Compounds 2-5 showed varied degree of antioxidant activity with IC 50 values of 2.1, 11.8, 15.3, and 4.1 µM, respectively. The key factor governing the antioxidant activity is attributed to phenolic hydroxyl. Among these values compounds 2 and 5 showed significant inhibition in comparison to the positive control, BHT, which had an IC 50 value 2.1 µM. Compounds 2 and 5 showed more potent activity than saururin (IC 50 8.5 µM) and virolin (IC 50 4.3 µM) from Saururus chinensis, the compound 2 was also more effective than machilin D (IC 50 2.9 µM), [Ahn et al., 2001] . This is first report of LDL oxidation activity for compounds 2-5. Compounds 1, 2, and 3 showed significant inhibitory activity on ACAT-1 with values of 63.4±6.9, 53.7±0.9, and 78.7±0.2%, respectively, and on ACAT-2 with values 47.3±1.5, 39.2±0.2, and 52.1±1.0%, respectively, at a concentration 50 mg/mL. The positive control OAA inhibited ACAT-1 by 36.6±1.5% and ACAT-2 by 36.0±0.6% at 0.1 µM (Table1). Compounds 1 and 3 Positive control of LDL-Oxidation, BHT, showed 85.0±0.3% inhibition at 3.0 µM with IC 50 value of 2.1 µM.
2
Positive control of ACAT-1, OAA, showed 33.6±1.5% inhibition at 0.1 µM with IC 50 value of 0.126 µM.
3
Positive control of ACAT-2, OAA, showed 36.0±0.6% inhibition at 0.1 µM with IC 50 value of 0.138 µM.
showed more potent activity than meso-dihydroguaiaretic acid from Myristica fragrans with ACAT 60.0±1.2% at concentration 100 mg/mL and compound 2 showed more potent activity than syringing methyl ether from M. fragrans with ACAT 27.2±0.9% at concentration 100 mg/mL [Song et al., 2004] and oleanolic acid from Albizia julibrissin with ACAT-1 52.5±0.7% and ACAT-2 22.0±2.6% at concentration 50 mg/mL [Baek et al., 2010] . This is first report of ACAT-1 and ACAT-2 inhibitory activity for compounds 1-5. Although compounds 1-5 had lower inhibition activity on ACAT-1 and ACAT-2 compared to positive control oleic acid anilide, the relative paucity of naturally occurring ACAT-1 and ACAT-2 inhibitors makes this report worth further investigation. There are few reports of LDLoxidation inhibitors, ACAT-1, and ACAT-2 from the natural resources. The compounds 2, 3, 4, and 5 exhibited similar activity for LDL-oxidation in comparison with the positive control. Compounds 1, 2, and 3 showed significant inhibitory activity on ACAT-1, and on ACAT-2. Therefore, the bark of M. thunbergii is used in oriental medicine in Korea can be useful source for treating hypercholesterolemia and atherosclerosis, and dementia. Among the active compounds, compound 2 appeared as the most potent inhibitor of LDL-oxidation with an IC 50 value of 2.1 µM and compound 3 as the most potent inhibitor of ACAT-1 and ACAT-2 with IC 50 value of 40.6 µM and 131.0 µM, respectively.
